多重向,没有门的CAR-T细胞作为一种策略,以保护血液癌症治疗的正常血统
Breanna DiAndreth1, Pavlo A Nesterenko1, Aaron G Winters1
1A2 Biotherapeutics Discovery Research, Agoura Hills, CA, United States.
Frontiers in immunology
|April 7, 2025
概括
工程Tmod细胞提供了治疗急性髓性白血病 (AML) 等血液癌症的新策略,通过向多个抗原,提高选择性和减少毒性以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法对血液癌症有前途,但面临着诸如目标上,瘤外毒性和导致复发的抗原损失等挑战.
- 现有的CAR-T疗法难以获得特异性,因为许多癌症点也存在于健康细胞上,限制了它们的治疗窗口.
研究的目的:
- 调整最初针对固体瘤开发的TmodTM逻辑门细胞系统,以提高血液癌症治疗的治疗选择性.
- 探索能够准多个抗原的Tmod细胞的设计,以提高血液恶性瘤治疗的精度.
主要方法:
- 应用了一个 NOT-gated TmodTM 系统来设计用于血液癌症应用的细胞疗法.
- 设计的Tmod细胞具有激活和抑制受体的组合,向特定的抗原,如CD33,CD43,CD16b和CLEC9A.
主要成果:
- 证明Tmod细胞可以被设计为针对2-4个抗原,提供多功能治疗选择.
- 展示了能够创建针对癌症抗原的激活受体 (CD33,CD43) 和针对正常细胞的抑制受体 (CD16b,CLEC9A) 的能力.
结论:
- 该Tmod系统表现出强大的模块化,扩展其适用性超越固体瘤到血液癌症.
- 这种方法提供了一个灵活的平台,用于开发更有选择性和潜在的少毒性细胞疗法,用于血液恶性瘤.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Tumor Immunotherapy
441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K


